Uscom Navigates Challenging Markets with Cost Controls and Product Progress

Uscom Limited (ASX: UCM) reported its Q4 FY25 4C cash flow, highlighting continued market headwinds and a focus on cost management. Customer receipts fell to $0.55 million, down 24% from the prior quarter and 64% year-over-year, reflecting weak sales in the U.S., Europe, and China, with only Southeast Asia meeting forecasts. Cash on hand was $0.97 million, down from $1.34 million, with operating cash outflow improving slightly to $0.72 million. Staff and marketing expenses dropped 30% year-over-year as the company maintained a defensive cost strategy. Uscom is advancing its BP+ central blood pressure technology, now qualified by the European Space Agency and installed on the International Space Station, and recently gained Chinese regulatory approval for its SpiroSonic devices. Management is prioritizing strategic partnerships and preparing for market recovery while targeting global expansion in cardiovascular and pulmonary diagnostics.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com